Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-25-002134
Filing Date
2025-03-31
Accepted
2025-03-31 16:42:20
Documents
83
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR DEC 2024 phio_i10k-123124.htm   iXBRL 10-K 1219506
2 FIRST AMENDMENT TO THE EMPLOYMENT AGREEMENT OF ROBERT J. BITTERMAN phio_ex1030.htm EX-10.30 6637
3 INSIDER TRADING POLICY phio_ex1901.htm EX-19.1 85954
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM phio_ex2301.htm EX-23.1 2210
5 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER phio_ex3101.htm EX-31.1 11163
6 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER phio_ex3102.htm EX-31.2 11133
7 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER phio_ex3201.htm EX-32.1 5460
13 GRAPHIC image_004.jpg GRAPHIC 768
14 GRAPHIC pic1.jpg GRAPHIC 47693
15 GRAPHIC pic2.jpg GRAPHIC 27295
16 GRAPHIC pic3.jpg GRAPHIC 39320
  Complete submission text file 0001683168-25-002134.txt   6089095

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE phio-20241231.xsd EX-101.SCH 43477
9 XBRL CALCULATION FILE phio-20241231_cal.xml EX-101.CAL 49795
10 XBRL DEFINITION FILE phio-20241231_def.xml EX-101.DEF 160420
11 XBRL LABEL FILE phio-20241231_lab.xml EX-101.LAB 401045
12 XBRL PRESENTATION FILE phio-20241231_pre.xml EX-101.PRE 325454
86 EXTRACTED XBRL INSTANCE DOCUMENT phio_i10k-123124_htm.xml XML 660055
Mailing Address 11 APEX DRIVE, SUITE 300A PMB 2006 MARLBOROUGH MA 01752
Business Address 11 APEX DRIVE, SUITE 300A PMB 2006 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36304 | Film No.: 25794120
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)